The expression and biological role of complement C1s in esophageal squamous cell carcinoma
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 19 (1) , 20220915
Abstract
The present work focused on investigating the role of the altered expression of complement C1s in proliferation and apoptosis of esophageal squamous cell carcinoma (ESCC) cells and explore its biological functions in ESCC, so as to lay a theoretical foundation and provide certain clinical reference for diagnosing and treating ESCC. Complement C1s expression within ESCC was assessed, and its clinical pathological characteristics in ESCC patients were analyzed. Subsequently, in vitro experiments were performed to further explore the mechanisms by which complement C1s affected ESCC. According to the results, complement C1s expression within ESCC markedly increased relative to adjacent non-cancerous samples. High C1s expression showed positive relation to race, residual lesion, and tumor location of ESCC patients. Complement C1s affected ESCC cell proliferation and apoptosis. Notably, C1s knockdown significantly inhibited ESCC cell proliferation and enhanced their apoptosis. C1s suppressed ESCC cell proliferation via Wnt1/β-catenin pathway and promoted their apoptosis through modulating the expression of Bcl2, Bax, and cleaved-caspase3.Keywords
This publication has 35 references indexed in Scilit:
- Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent AdvancesJournal of Gastrointestinal Cancer, 2023
- Esophageal Cancer StagingThoracic Surgery Clinics, 2022
- Endoscopic Management of Esophageal CancerThoracic Surgery Clinics, 2022
- Wnt signaling pathway: A comprehensive reviewCell Biology International, 2022
- Update on Management of Squamous Cell Esophageal CancerCurrent Oncology Reports, 2022
- Universal and cross‐cancer prognostic biomarkers for predicting survival risk of cancer patients from expression profile of apoptotic pathway genesProteomics, 2021
- Functional recombinant human complement C1q with different affinity tagsJournal of Immunological Methods, 2021
- Nucleolin acts as the receptor for C1QTNF4 and supports C1QTNF4-mediated innate immunity modulationJournal of Biological Chemistry, 2021
- Advanced squamous cell carcinoma in an asymptomatic, large, epiphrenic esophageal diverticulumClinical Journal of Gastroenterology, 2020
- Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancerBiochemical and Biophysical Research Communications, 2012